Snail_pGL2 Citations (14)

Originally described in: MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.
Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA Cell. 2003 Apr 18. 113(2):207-19. PubMed Journal

---

Articles Citing Snail_pGL2

Articles
IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG). Zirkel A, Lederer M, Stohr N, Pazaitis N, Huttelmaier S. Nucleic Acids Res. 2013 Jul;41(13):6618-36. doi: 10.1093/nar/gkt410. Epub 2013 May 15. PubMed
Functional links between Snail-1 and Cx43 account for the recruitment of Cx43-positive cells into the invasive front of prostate cancer. Ryszawy D, Sarna M, Rak M, Szpak K, Kedracka-Krok S, Michalik M, Siedlar M, Zuba-Surma E, Burda K, Korohoda W, Madeja Z, Czyz J. Carcinogenesis. 2014 Sep;35(9):1920-30. doi: 10.1093/carcin/bgu033. Epub 2014 Feb 6. PubMed
Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis. Xie Y, Liu S, Lu W, Yang Q, Williams KD, Binhazim AA, Carver BS, Matusik RJ, Chen Z. Mol Oncol. 2014 Oct;8(7):1355-64. doi: 10.1016/j.molonc.2014.05.006. Epub 2014 May 21. PubMed
Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-kappaB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection. Wu TJ, Chang SS, Li CW, Hsu YH, Chen TC, Lee WC, Yeh CT, Hung MC. Clin Cancer Res. 2015 Dec 11. PubMed
The RNA-binding protein ESRP1 promotes human colorectal cancer progression. Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfo I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F. Oncotarget. 2017 Feb 7;8(6):10007-10024. doi: 10.18632/oncotarget.14318. PubMed
Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition. Al-Hattab DS, Safi HA, Nagalingam RS, Bagchi RA, Stecy MT, Czubryt MP. Am J Physiol Heart Circ Physiol. 2018 Sep 1;315(3):H658-H668. doi: 10.1152/ajpheart.00092.2018. Epub 2018 Jun 15. PubMed
Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide. Lu P, White-Gilbertson S, Nganga R, Kester M, Voelkel-Johnson C. Cancer Biol Ther. 2019;20(6):922-930. doi: 10.1080/15384047.2019.1579962. Epub 2019 Mar 5. PubMed
UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Wang X, Liu R, Zhu W, Chu H, Yu H, Wei P, Wu X, Zhu H, Gao H, Liang J, Li G, Yang W. Nature. 2019 Jul;571(7763):127-131. doi: 10.1038/s41586-019-1340-y. Epub 2019 Jun 26. PubMed
Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells. Yang M, Li Z, Tao J, Hu H, Li Z, Zhang Z, Cheng F, Sun Y, Zhang Y, Yang J, Wei H, Wu Z. J Cancer Res Clin Oncol. 2021 Apr;147(4):1101-1113. doi: 10.1007/s00432-021-03510-z. Epub 2021 Jan 20. PubMed
Temozolomide Induces the Acquisition of Invasive Phenotype by O6-Methylguanine-DNA Methyltransferase (MGMT)(+) Glioblastoma Cells in a Snail-1/Cx43-Dependent Manner. Kochanowski P, Catapano J, Pudelek M, Wrobel T, Madeja Z, Ryszawy D, Czyz J. Int J Mol Sci. 2021 Apr 16;22(8). pii: ijms22084150. doi: 10.3390/ijms22084150. PubMed
Urolithin A Inhibits Epithelial-Mesenchymal Transition in Lung Cancer Cells via P53-Mdm2-Snail Pathway. Cheng F, Dou J, Zhang Y, Wang X, Wei H, Zhang Z, Cao Y, Wu Z. Onco Targets Ther. 2021 May 17;14:3199-3208. doi: 10.2147/OTT.S305595. eCollection 2021. PubMed
Retinoic Acid-Inducible Gene I-Like Receptors Activate Snail To Limit RNA Viral Infections. Vedagiri D, Gupta D, Mishra A, Krishna G, Bhaskar M, Sah V, Basu A, Nayak D, Kalia M, Valiya Veettil M, Harshan KH. J Virol. 2021 Oct 13;95(21):e0121621. doi: 10.1128/JVI.01216-21. Epub 2021 Aug 11. PubMed
Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/beta-arr1 Axis. Del Rio D, Masi I, Caprara V, Spadaro F, Ottavi F, Strippoli R, Sandoval P, Lopez-Cabrera M, Sainz de la Cuesta R, Bagnato A, Rosano L. Front Cell Dev Biol. 2021 Dec 1;9:764375. doi: 10.3389/fcell.2021.764375. eCollection 2021. PubMed
Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer. Zhang Z, Wang X, Kim M, He D, Wang C, Fong KW, Liu X. Prostate. 2023 Jul 20. doi: 10.1002/pros.24602. PubMed

If you have published an article using this material, please email us at to have your article added to this page.